📰 Matt Pullen News
Page 3 - Matt Pullen News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Matt Pullen. Real-time updates on events, politics, business and more.
August 18, 2022
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
August 1, 2022
Sail World - The world's largest sailing news network; sail and sailing, cruising, boating news
May 19, 2022
Investegate announcements from Genuit Group PLC, Result of AGM
May 19, 2022
DH Property Holdings, LLC, a leading developer and owner of urban infill industrial logistics facilities, announced its acquisition of a development site in Malden, Massachusetts. The fully entitled, five-acre industrial zoned property will soon be developed into a 94,095-square-foot, Class-A industrial facility in a joint venture with local developer Pugh...
March 23, 2022
Investegate announcements from Genuit Group PLC, Director/PDMR Shareholding
March 4, 2022
How can data centre operators help lessen their impact on climate change?
November 22, 2021
With Christmas just over a month away, local toy drives have kicked off and early indications are that the need in the Owen Sound area is as high as it has…
November 22, 2021
With Christmas just over a month away, local toy drives have kicked off and early indications are that the need in the Owen Sound area is as high as it has…
July 23, 2021
Nationwide COVID-OUT treatment trial with ivermectin is underway Phoenix Herald 23 Jul 2021, 10 GMT+10 An ongoing COVID-19 clinical trial studying the outpatient use of metformin, a generic medication for type 2 diabetes, has expanded and will now be the nations first to include fluvoxamine, an antidepressant, and ivermectin, an antiparasitic, as possible treatment options to prevent hospitalization and "long COVID." Led by the University of Minnesota Medical School, the multi-site clinical tri...
May 25, 2021
E-Mail MINNEAPOLIS/ST. PAUL (05/25/2021) -- An ongoing COVID-19 clinical trial studying the outpatient use of metformin, a generic medication for type 2 diabetes, has expanded and will now be the nations first to include fluvoxamine, an antidepressant, and ivermectin, an antiparasitic, as possible treatment options to prevent hospitalization and "long COVID." Led by the University of Minnesota Medical School, the multi-site clinical trial received new support - $1 million from the Rainwater C...